CTSH
Pro-cathepsin H
Also known as: ACC-4, ACC-5, ACC4, ACC5, CATH_HUMAN, CPSB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09668
- Gene
- CTSH
- Ensembl
- ENSG00000103811
- Chromosome
- 15
- Canonical length
- 335 aa
- Protein class
- Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol,Cytoplasmic bodies
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a lysosomal cysteine proteinase important in the overall degradation of lysosomal proteins. It is composed of a dimer of disulfide-linked heavy and light chains, both produced from a single protein precursor. The encoded protein, which belongs to the peptidase C1 protein family, can act both as an aminopeptidase and as an endopeptidase. Increased expression of this gene has been correlated with malignant progression of prostate tumors. Alternate splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
335 residues, UniProt reviewed canonical sequence.
>P09668|CTSH
1 MWATLPLLCA GAWLLGVPVC GAAELCVNSL EKFHFKSWMS KHRKTYSTEE YHHRLQTFAS
61 NWRKINAHNN GNHTFKMALN QFSDMSFAEI KHKYLWSEPQ NCSATKSNYL RGTGPYPPSV
121 DWRKKGNFVS PVKNQGACGS CWTFSTTGAL ESAIAIATGK MLSLAEQQLV DCAQDFNNHG
181 CQGGLPSQAF EYILYNKGIM GEDTYPYQGK DGYCKFQPGK AIGFVKDVAN ITIYDEEAMV
241 EAVALYNPVS FAFEVTQDFM MYRTGIYSST SCHKTPDKVN HAVLAVGYGE KNGIPYWIVK
301 NSWGPQWGMN GYFLIERGKN MCGLAACASY PIPLVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTSH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 330 nTPM
Expression across tissuesHPA
Tissue
- lung: 330 nTPM
- kidney: 222 nTPM
- urinary bladder: 189 nTPM
- lymph node: 180 nTPM
- tonsil: 123 nTPM
- cervix: 106 nTPM
Single-cell type
- alveolar cells type 2: 1,745 nCPM
- epididymal efferent duct absorptive cells: 766 nCPM
- transitional alveolar cells: 508 nCPM
- urothelial cells: 430 nCPM
- cdc: 386 nCPM
- cholangiocytes: 370 nCPM
Immune cell
- classical monocyte: 210 nTPM
- myeloid DC: 184 nTPM
- total PBMC: 148 nTPM
- intermediate monocyte: 138 nTPM
- non-classical monocyte: 95 nTPM
- memory B-cell: 84 nTPM
Brain region
- thalamus: 13 nTPM
- hypothalamus: 13 nTPM
- white matter: 12 nTPM
- medulla oblongata: 9.8 nTPM
- choroid plexus: 9.4 nTPM
- midbrain: 9.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTSH.
Disease | ImmuneIEDB
Conditions an epitope on CTSH was assayed in.
- chronic lymphocytic leukemia T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation
- bradykinin catabolic process
- cellular response to thyroid hormone stimulus
- ERK1 and ERK2 cascade
- immune response
- immune response-regulating signaling pathway
- lysosomal protein catabolic process
- membrane protein proteolysis
- metanephros development
- neuropeptide catabolic process
- positive regulation of apoptotic signaling pathway
- positive regulation of cell migration
- positive regulation of epithelial cell migration
- positive regulation of gene expression
- protein destabilization
- proteolysis
- proteolysis involved in protein catabolic process
- response to odorant
- response to retinoic acid
- spermatogenesis
- surfactant homeostasis
- T cell mediated cytotoxicity
- zymogen activation
- dichotomous subdivision of terminal units involved in lung branching
Molecular functions
- aminopeptidase activity
- cysteine-type endopeptidase activator activity involved in apoptotic process
- cysteine-type endopeptidase activity
- cysteine-type peptidase activity
- endopeptidase activity
- HLA-A specific activating MHC class I receptor activity
- identical protein binding
- kininogen binding
- peptidase activity
- protein-containing complex binding
- serine-type endopeptidase activity
- thyroid hormone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine peptidase, cysteine active site
- Peptidase C1A, papain C-terminal
- Peptidase C1A
- Cathepsin propeptide inhibitor domain (I29)
- Cysteine peptidase, histidine active site
- Cysteine peptidase, asparagine active site
- Papain-like cysteine peptidase superfamily
- Papain-like cysteine endopeptidase
- Papain family cysteine protease
- Cathepsin propeptide inhibitor domain (I29)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CTSH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTSH as an antibody target. Whether an autoantibody or antibody against CTSH could matter depends on whether native CTSH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTSH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTSH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...